Smoking and diabetes mellitus

Netherlands Journal of Medicine

Volumn 48, Issue 4, 1996, Pages 150-162

  Dierkx, R I J ^a,e   Van De Hoek, W ^b   Hoekstra, J B L ^c   Erkelens, D W ^d  

^a ST JOSEPH HOSPITAL   (Netherlands)

^b EEMLAND HOSPITAL   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e NONE   (Netherlands)

Author keywords

anti smoking programmes; diabetes mellitus; diabetic complications; insulin action and metabolism; smoking; smoking prevalence

Indexed keywords

INSULIN; ORAL CONTRACEPTIVE AGENT;

FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; MALE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW; SMOKING; SMOKING CESSATION;

EID: 0029897465     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(96)80018-0     Document Type: Review

References (108)

1. Jones RB, Hedley AJ. Prevalence of smoking in a diabetic population: The need for action. Diabet Med 1987;4:233-236.
2. Kesson CM. Smoking in diabetics (Letter). Lancet 1979;1:504-505.
3. Ford ES, Newman J. Smoking and diabetes mellitus. Findings from 1988 behavioral risk factor surveillance system. Diabetes Care 1991;14(10):871-874.
4. Telmer S, Sandahl Christiansen J, Andersen AR, Nerup J, Deckert T. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 1984;215:63-68.
5. Czyzyk A, Krolewski AS. Is cigarette smoking more frequent among insulin-treated diabetics? Diabetes 1976;25:717-718.
6. Gay E.C, Cai Y, Gale SM, et al. Smokers with IDDM experience excess morbidity. Diabetes Care 1992;15(8): 947-952.
7. Roberts M. Smoking and diabetes. Nurs Times 1992;88(8):59-60.
8. Moy CS, Laporte RE, Dorman JS, et al. Insulin-dependent diabetes mellitus mortality: the risk of cigarette smoking. Circulation 1990;82:37-43.
9. Nielsen MM, Hjollund E. Smoking and diabetic microangiopathy. Lancet 1978;2:533-534.
10. Songer TJ. What impact does insulin dependent diabetes mellitus (IDDM) have upon health behaviors? Diabetes 1988;37(suppl 1):124A(Abstract).
11. Masson EA, MacFarlane IA, Priestly CJ, Wallymahmed ME, Flavell HJ. Failure to prevent nicotine addiction in young people with diabetes. Arch Dis Child 1992;67:100-102.
12. Shaw NJ, McClure RJ, Kerr S, Lawton K, Smith CS. Smoking in diabetic teenagers. Diabet Med 1993;10(3): 275-277.
13. Bott U, Jorgens V, Grusser M, Bender R, Muhlhauser I, Berger M. Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 1994;11(4):362-371.
14. Haire-Joshu D, Heady S, Thomas L, Schechtman K, Fisher EB. Depressive symptomatology and smoking among persons with diabetes. Res Nurs Health 1994;17(4):273-282.
15. Dasvis WK, Hess GE, Hiss RG. Psychosocial correlates of survival in diabetes. Diabetes Care 1988;11(7):538-545.
16. Fielding JE. Smoking: Health effects and control. N Engl J Med 1985;313:491-498.
17. Klein R, Klein BEK, Davis MD. Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol 1983;118:228-238.
18. Thorell B, Olsson L, Svardsudd K. Implementation of a structured care programme for diabetes mellitus in a defined population in mid-Sweden. Diabet Med 1994;11(5):458-464.
19. Dintenfass L. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels in cigarette smokers. Med J Aust 1975;1:617-620.
20. Ganda OMP. Pathogenesis of macrovascular disease in the human diabetic. Diabetes 1980;29:931-942.
21. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
22. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 1986;315:1305-1309.
23. Muhlhauser I. Cigarette smoking and diabetes: an update. Diabet Med 1994;11:336-343.
24. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989;298:784-788.
25. Connell FA, Louden JM. Diabetes mortality in persons under 45 years of age. Am J Publ Health 1983;73:1174-1177.
26. Lestradet H, Papoz L, Hellouin de Menibus CL, et al. Long-term study of mortality and vascular complications in juvenile-onset (Type 1) diabetes. Diabetes 1981;30:175-179.
27. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. J Am Med Assoc 1979;241:2035-2038.
28. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes mellitus. Am J Cardiol 1987;59:750-755.
29. DeStefano F, Ford ES, Newman J, et al. Risk factors for coronary heart disease mortality among persons with diabetes. Ann Epidemiol 1993;3(1):27-34.
30. Fowkes FG, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135(4):331-340.
31. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 1979;59:8-13.
32. Jarrett RJ, Shipley MJ. Mortality and associated risk factors in diabetes. Acta Endocrinol 1985;110(suppl 272):21-26.
33. Betteridge DJ. Diabetic dyslipidemia. Am J Med 1994;96(6A):25S-31S.
34. Goldschmid MG, Barrett-Connor E, Edelstein SL, Wingard DL, Cohn BA, Herman WH. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 1994;89(3):991-997.
35. Stanton K. H.D.L. cholesterol in diabetes and heart disease. Lancet 1978;2:638.
36. Macfarlane IA. The smoker with diabetes: a difficult challenge. Postgrad Med J 1991;67(792):928-930.
37. Suarez L, Barrett-Connor E. Interaction between cigarette-smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 1984;120:670-675.
38. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. Ann Intern Med 1977;87:393-397.
39. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 1974;23:105-111.
40. Waldern WE, Knopp RH, Wahl PW, Beach KW, Strandness DE. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984;311:953-959.
41. Croft P, Hannaford PC. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. Br Med J 1989;298:165-168.
42. Muhlhauser I, Sawicki P, Berger M. Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1986;500-502.
43. Christiansen JS. Cigarette smoking and the prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1978;1:146-149.
44. Norden G, Nyberg G. Smoking and diabetic nephropathy. Acta Med Scand 1984;215:257-261.
45. Saegmayr B, Lithner F. Tobacco and end stage diabetic nephropathy. Br Med J 1987;295:581-582.
46. Borch-Johnson K, Nissen H, Henriksen E, et al. The natural history of insulin-dependent diabetes mellitus in Denmark. 1. Long-term survival with and without late diabetic complications. Diabetic Med 1987;4:201-210.
47. Kumar S. American diabetes association annual scientific sessions, San Antonio, 20-23 June 1992. Diabet Med 1992;9(10):957-959.
48. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann L, Berger M. Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994;17(2):126-131.
49. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom. Br Med J 1993;306(6887):1235-1239.
50. Olivarius N de F, Andreasen AH, Keiding N, Mogensen CE. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark. Diabetologia 1993;36(10):1007-1016.
51. Klein R, Klein BE, Moss SE. Incidence of gross proteinuria in older-onset diabetes. A population-based perspective. Diabetes 1993;42(3):381-389.
52. Paetkau ME, Boyd TAS, Winship B, Grace M. Cigarette smoking and diabetic retinopathy. Diabetes 1977;26:46-49.
53. Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994;101(6):1061-1070.
54. Marshall G, Garg SK, Jackson WE, Holmes DL, Chase HP. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 1993;100(8):1133-1139.
55. Sparrow JM, McLeod BK, Smith TD, Birch MK, Rosenthal AR. The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye 1993;7(Pt 1):158-163.
56. Madsbad S, McNair P, Christensen MS. Influence of smoking on insulin requirement and metabolic status in diabetes mellitus. Diabetes Care 1980;3:41-43.
57. The World Health Organisation multinational study of vascular disease in diabetics. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. Diabetologia 1985;28:615-640.
58. West KM, Erdreich LS, Stober JA. Absence of a relationship between smoking and diabetic microangiopathy. Diabetes Care 1980;3:250-252.
59. West KM, Ahuja MMS, Bennett PH, et al. Interrelationship of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: a multinational study. Diabetologia 1982;22:412-420.
60. Dornan T, Mann JI, Turner R. Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years. Br Med J 1982;285:1073-1077.
61. Rand LI, Krolewski AS, Aiello LM, Warram JH, Baker RS, Maki T. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985;313:1433-1438.
62. Simpson LO. Intrinsic stiffening of red blood cells as the fundamental cause of diabetic nephropathy and microangiopathy: a new hypothesis. Nephron 1985;39: 344-351.
63. Simpson LO, Shand BI, Olds RJ. A reappraisal of the influence of blood rheology on glomerular filtration and its role in the pathogenesis of diabetic nephropathy. J Diabet Complicat 1987;1:137-144.
64. Bodmer CW, Valentine DT, Masson EA, Savage MW, Lake D, Williams G. Smoking attenuates the vasoconstrictor response to noradrenaline in type 1 diabetic patients and normal subjects: possible relevance to diabetic nephropathy. Eur J Clin Invest 1994;24(5):331-336.
65. Eadington DW, Patrick AW, Collier A, Frier BM. Limited joint mobility, Dupuytren's contracture and retinopathy in Type 1 diabetes: association with cigarette smoking. Diabetic Med 1989;6:152-157.
66. Mitchell BD, Hawthorne VM, Vinik AI. Increased prevalence of neuropathy associated with cigarette smoking in IDDM. Diabetes 1989;39(suppl 2):16A (Abstract).
67. Cruickshanks KJ, Gay E, Hamman RF. Smoking is related to symptoms of neuropathy in a cohort of young subjects with insulin-dependent diabetes mellitus (IDDM). Diabetes 1989;39(suppl 2):35A(Abstract).
68. Muhlhauser I. Smoking and diabetes. Diabetic Med 1990;7:10-15.
69. Wang CJ, Shen SY, Wu CC, Huang CH, Chiang CP. Penile blood flow study in diabetic impotence. Urol Int 1993;50(4):209-212.
70. Genco RJ. Assessment of risk of periodontal disease. Compendium 1994;(suppl 18):S678-683:quiz S714-717.
71. Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL. Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol 1993;64(1): 16-23.
72. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. 1. Risk indicators for attachment loss. J Periodontol 1994;65(3):260-267.
73. Balkau B, Barrett-Connor E, Eschwege E, Richard JL, Claude JR, Ducimetiere P. Diabetes and pancreatic carcinoma. Diabet Metab 1993;19(5):458-462.
74. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YDI, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-1130.
75. Roth GM, Shick RM. Effect of smoking on the cardiovascular system of man. Circulation 1958;17:443-459.
76. Dreibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 1980;65:717-721.
77. Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 1982;55:973-983.
78. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 1982;54:131-138.
79. Epifano L, Di Vincenzo A, Fanelli C, et al. Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus. Eur J Clin Pharmacol 1992;43:257-263.
80. West KM. Association of smoking with insulin requirement and serum triglyceride level. Diabetes Care 1980;3:641.
81. Mathiesen ER, Soegaard U, Christiansen JS. Smoking and glycemic control in male insulin dependent (Type 1) diabetics. Diabetes Res 1984;1:155-157.
82. Helve E, Yki-Jarvinen H, Koivisto VA. Smoking and insulin sensitivity in Type 1 diabetic patients. Metabolism 1986;35:874-877.
83. Klemp P, Staberg B, Madsbad S, Kolendorf K. Smoking reduces insulin absorption from subcutaneous tissue. Br Med J 1982;284:237.
84. Muhlhauser I, Cuppers HJ, Berger M. Smoking and insulin absorption from subcutaneous tissue. Br Med J 1984;288:1875-1876.
85. Yki-Jarvinen H, Taskinen M-R, Kiviluoto T, et al. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. J Clin Endocrinol Metab 1984;59:1183-1192.
86. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance - a potential link with the insulin resistance syndrome. J Intern Med 1993;233:327-332.
87. Baer L, Radichevich I. Cigarette smoking in hypertensive patients - blood pressure and endocrine responses. Am J Med 1985;78:564-568.
88. Rizza RA, Cryer PE, Haymond MW, Gerich JE. Adrenergic mechanism for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 1980;65:682-689.
89. Clutter WE, Brier DM, Shah SD, Cryer PE. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 1980;66:94-101.
90. Ague C. Urinary catecholamines, flow rate and tobacco smoking. Biol Psychol 1974;1:229-236.
91. Newton MA, Laragh JH. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism. J Clin Metab 1968;28:1006-1013.
92. Rimm EB, Manson JE, Stampfer MJ, et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health 1993;83(2):211-214.
93. Feskens EJ, Kromhout D. Cardiovascular risk factors and the 25-years incidence of diabetes mellitus in middle-aged men. Am J Epidemiol 1989;130:1101-1108.
94. Modan M, Meytes D, Rozeman P, et al. Significance of high HbA1 levels in normal glucose tolerance. Diabetes Care 1988;11(5):422-428.
95. Fowler PM, Hoskins PL, McGill M, Dutton SP, Yue DK, Turtle JR. Anti-smoking programme for diabetic patients: the agony and the ecstasy. Diabetic Med 1989;6:698-702.
96. Pederson L. Compliance with physician advice to quit smoking: a review of the literature. Prev Med 1982;11:71-84.
97. Ardron M, MacFarlane IA, Robinson C, Heyningen C, Calverley PMA. Antismoking advice for young diabetic smokers: is it a waste of breath? Diabetic Med 1988;5:667-670.
98. Spangler JG, Konen JC. Predicting exercise and smoking behaviors in diabetic and hypertensive patients. Age, race, sex, and psychological factors. Arch Fam Med 1993;2(2):149-155.
99. Hess GE, Davis WK, Harrison RV. A diabetes psychosocial profile. Diabetes Educ 1986;12:135-140.
100. Davis WK, Hess GE, Harrison RV, Hiss RG. Psychosocial adjustment to and control of diabetes mellitus: differences by disease type and treatment. Health Psychol 1987;6:1-14.
101. Glass DC. Stress, behavior patterns, and coronary disease. Am Sci 1977;65:177-187.
102. Rosenman RH. Role of type A behavior pattern in the pathogenesis of ischemic heart disease, and modification for prevention. Adv Cardiol 1978;25:35-46.
103. Murawski BJ, Chazan BI, Balodimos MC, Ryan JR. Personality patterns in patients with diabetes mellitus of long duration. Diabetes 1970;19:259-263.
104. Friedman M, Byers SO, Diamant J, Rosenman R. Plasma catecholamine response of coronary-prone subjects (type A) to a specific challenge. Metabolism 1975;24:205-210.
105. Russel MAH, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. Br Med J 1979;ii:231-235.
106. Tonnesen P, Fryd V, Hansen M, et al. Effect of nicotine chewing gum in combination with group counselling on the cessation of smoking. N Engl J Med 1988;318:15-18.
107. Burt A, Illingworth D, Shaw T, Thornley P, White P, Turner R. Stopping smoking after myocardial infarction. Lancet 1974;1:304-306.
108. Sawicki PT, Didjurgeit U, Muhlhauser I, Berger M. Behaviour therapy versus doctor's anti-smoking advice in diabetic patients. J Intern Med 1993;234(4):407-409.